About the Journal

• Peer-reviewed journal
• Available online
• Six issues per year
• eISSN: 2380-9612; ISSN: 2380-9604 (Final Print Issue November/December 2025)
• Address: 70 East Swedesford Road, Suite 100
  Malvern, PA 19355

Journal of Clinical Pathways^® (JCP) is the only peer-reviewed digital publication solely dedicated to the in-depth exploration of oncology clinical pathways—a critical area of cancer care that is not covered with comparable rigor or focus in any other journal. What truly sets JCP apart is its multidisciplinary editorial board, which brings together health care providers, researchers, payers, and clinical pathways experts. This diverse representation ensures that every piece published reflects the perspectives and needs of all key stakeholders involved in the delivery of value-based cancer care.

JCP serves as a vital forum for educational and scholarly articles on the development, implementation, and evaluation of oncology clinical pathways. It covers a wide array of relevant and emerging topics, including:

• Comparative-effectiveness research
• Big data analytics
• Methodologies in pathway development
• Implementation science and adherence strategies
• Health economics and outcomes research
• Patient-centered outcomes
• Alternative payment and value-based care models

JCP's mission is to drive forward the conversation around oncology clinical pathways as a transformative tool for delivering high-quality, cost-effective care—especially as the health care system transitions from fee-for-service to value-based models. Clinical pathways unite real-world data with clinical decision-making to promote precision, consistency, and optimal outcomes in cancer care.

In every issue, JCP investigates how pathways can help address some of the most pressing challenges in oncology: controlling rising costs, minimizing patient risk, reducing unwarranted care variation, and improving outcomes. More than just a journal, JCP functions as a collaborative platform for stakeholders across the spectrum—oncologists, payers, researchers, and health care leaders—to share insights, report on real-world applications, and showcase the impact of pathway-driven approaches within their institutions.

Unlike broader publications that touch on health economics or clinical research tangentially, JCP maintains a laser focus on clinical pathways in oncology. This singular commitment, supported by a uniquely qualified editorial board, makes JCP the definitive resource for advancing clinical pathways as a cornerstone of value-based cancer care.

Subscribe now to receive the latest issue updates.

Alan Balch, PhD, has more than 22 years of executive leadership experience in the nonprofit health sector, with a focus on access and affordability, health equity, prevention and early detection, and cancer research. He has served as Chief Executive Officer of the Patient Advocate Foundation (PAF) and National Patient Advocate Foundation (NPAF) since 2013 and has been a member of both organizations’ boards since 2007. Previously, Dr Balch was Vice President of the Preventive Health Partnership—a national collaboration among the American Cancer Society, American Diabetes Association, and American Heart Association—and Executive Director of Friends of Cancer Research. He currently serves or has recently served on numerous national boards, councils, and steering committees, including the National Academies of Medicine, National Quality Forum, NCQA, ICER, ISPOR, and the Duke-Margolis Value-Based Payment Consortium. Dr Balch serves as Editor-in-Chief of the Journal of Clinical Pathways and is on the advisory board for the Journal of Oncology Navigation and Survivorship. He earned his PhD from the University of California, Santa Cruz; his master’s degree from the University of Texas at San Antonio; and his bachelor’s degree from Trinity University in San Antonio.

HMP Global is the omnichannel market leader in healthcare events, education, and insight — with a mission to improve patient care. For 40 years, the company has built trusted brands including Psych Congress, the premier source for mental health education, and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. HMP Global partners with leading experts around the world to deliver more than 450 annual events, medical strategy, and marketing for pharmaceutical and medical device customers through HMP Collective, and pharmaceutical market insight, engaging a global community of healthcare stakeholders that includes nearly 2 million clinicians across 600 medical specialties as well as managed care, behavioral health, senior living, emergency medical, and pharmaceutical commercialization professionals. For more information, follow HMP Global on LinkedIn or visit hmpglobal.com.